Vimarsana
Biggest News Aggregation in the World

Page 5 - Technologies Munich News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Technologies Munich. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Technologies Munich Today - Breaking & Trending Today

ITM Opens World's Largest Lutetium-177 Production Facility for Targeted Radionuclide ... - Vimarsana News

ITM Opens World's Largest Lutetium-177 Production Facility for Targeted Radionuclide ...

New manufacturing plant in Neufahrn near Munich increases ITM's production capacity tenfoldCeremonial opening by Minister of State, Dr. Florian Herrmann, Head of the Bavarian State Chancellery

ITM Isotope Technologies Munich brings US headquarters to NJ - Vimarsana News

ITM Isotope Technologies Munich brings US headquarters to NJ

ITM Isotope Technologies Munich is a leader in Targeted Radionuclide Therapy, an emerging class of cancer treatment.

Four Reasons Jamaican Canadian Billionaire Michael Lee-Chin Is Taking Three-Month Leave - Vimarsana News

Four Reasons Jamaican Canadian Billionaire Michael Lee-Chin Is Taking Three-Month Leave

On May 24, 2023, it was reported in The Gleaner newspaper that Jamaican Canadian billionaire and executive chair of the National Commercial Bank (NCB,) Michael Lee-Chin, will take a three-month leave of absence to “focus on pressing business and personal matters.”

ITM Isotope Technologies Munich SE: ITM Enters Cooperation Agreement with Paul Scherrer Institute (PSI) for Co-Development and Upscaled Manufacturing of Terbium-161 for Theranostic Application in Cancer - Vimarsana News

ITM Isotope Technologies Munich SE: ITM Enters Cooperation Agreement with Paul Scherrer Institute (PSI) for Co-Development and Upscaled Manufacturing of Terbium-161 for Theranostic Application in Cancer

Enhancement of ITM's development and manufacturing activities strengthens ITM's position as a pioneer and leader in Targeted Radionuclide Therapy (TRT) Garching / Munich, April 27, 2023 - ITM Isotope

ITM Enters Cooperation Agreement with Paul Scherrer - Vimarsana News

ITM Enters Cooperation Agreement with Paul Scherrer

Enhancement of ITM’s development and manufacturing activities strengthens ITM’s position as a pioneer and leader in Targeted Radionuclide Therapy (TRT) ...